← Product Code [IPF](/submissions/PM/subpart-f%E2%80%94physical-medicine-therapeutic-devices/IPF) · K091248 # MAXEMS, MODELS 1000 AND 2000 (K091248) _Bio Protech, Inc. · IPF · Nov 30, 2009 · Physical Medicine · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/PM/subpart-f%E2%80%94physical-medicine-therapeutic-devices/IPF/K091248 ## Device Facts - **Applicant:** Bio Protech, Inc. - **Product Code:** [IPF](/submissions/PM/subpart-f%E2%80%94physical-medicine-therapeutic-devices/IPF.md) - **Decision Date:** Nov 30, 2009 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 890.5850 - **Device Class:** Class 2 - **Review Panel:** Physical Medicine - **Attributes:** Therapeutic ## Indications for Use 1. Relax muscles 2. Prevention or retardation of disuse atrophy 3. Increasing local blood circulation 4. Muscle re-education 5. Immediate post-surgical stimulation of calf muscle to prevent venous thrombosis 6. Maintaining or increasing range of motion ## Device Story MAXEMS 1000/2000 are battery-operated pulse generators delivering electrical impulses to muscle groups via external electrodes. Device features two independent output channels. MAXEMS 1000 is an analogue unit with selectable pulse rates (5, 30, 100 Hz); MAXEMS 2000 is a digital unit with adjustable pulse rates (1-150 Hz). Used with standard carbon film electrodes (minimum 48mm x 48mm, impedance <2k ohms). Operated by clinicians or patients to stimulate muscles for therapeutic purposes, including post-surgical venous thrombosis prevention and atrophy management. ## Clinical Evidence No clinical data included. Substantial equivalence based on non-clinical testing. ## Technological Characteristics Battery-operated pulse generator; dual independent output channels; analogue (1000) or digital (2000) control; pulse rate 1-150 Hz; uses standard carbon film electrodes (biocompatible adhesive, >48mm x 48mm, <2k ohms impedance). ## Regulatory Identification A powered muscle stimulator is an electrically powered device intended for medical purposes that repeatedly contracts muscles by passing electrical currents through electrodes contacting the affected body area. ## Predicate Devices - EMS 5.O ([K072795](/device/K072795.md)) - EV-807 Digital EMS ([K020750](/device/K020750.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ Kogizys ### SECTION 5 - 510(k) Summary or 510(k) Statement This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of 21 CFR 807.92 APPLICANT: Bio Protech PHONE: (82) 33-747-1095 NOV 3 0 2009 FAX: (82) 33-747-1097 CONTACT PERSON: Ms. Anna Kim OFFICIAL CORRESPONDENT: Ms. Judy Burton, Advena Ltd. ADDRESS: 2626 Valley View Lane, Suite 4, Dallas, Texas 75234-6274 PHONE: (972) 243-5105 FAX: (972) 243-1542 DATE OF SUMMARY: November 25, 2009 TRADE NAME: MAXEMS 1000 / MAXEMS 2000 COMMON NAME: EMS CLASSIFICATION NAME: Stimulator, Muscle, Powered CLASSIFICATION CODE: IPF REGULATION NO.: 890.5850 PREDICATE DEVICES: K072795 EMS 5.O / K020750 EV-807 Digital EMS DEVICE DESCRIPTION: The MAXEMS are battery operated pulse generators that send electrical impulses through electrodes to the body and reach the underlying muscle group. The devices are provided with two controllable output channels, each independent of each other. An electrode pair can be connected to each output channel. Use of legally marketed, standard carbon film electrodes with a biocompatible adhesive, that are a minimum of 48mmx48mm in size and have an impedance of less than 2k ohms is recommended. The MAXEMS 1000 is an analogue unit with dual channels and a selectable pulse rate of 5, 30, and 100 Hz. The MAXEMS 2000 is a digital unit with an adjustable pulse rate from 1 to 150Hz. {1}------------------------------------------------ ### INTENDED USE: - 1. Relax muscles - Prevention or retardation of disuse atrophy 2. - Increasing local blood circulation ల్ల - Muscle re-education ঞ্চ - Immediate post-surgical stimulation of calf muscle to prevent venous thrombosis 5. - Maintaining or increasing range of motion 6. DETERMINATION OF SUBSTANTIAL EQUIVALENCE BASED ON CLINICAL DATA: No clinical data has been included in this submission. CONCLUSIONS DRAWN FROM NON-CLINICAL TESTS: The MAXEMS series is as safe and effective as the predicate devices cited above. {2}------------------------------------------------ Image /page/2/Picture/1 description: The image shows the seal of the U.S. Department of Health & Human Services. The seal features a stylized eagle with its wings spread, facing right. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" are arranged in a circular pattern around the eagle. The text is in all caps and appears to be in a sans-serif font. Food and Drug Administration 10903 New Hampshire Avenue Document Control Room W-066-0609 Silver Spring, MD 20993-0002 Bio Protech, Inc. % Advena, Ltd. Ms. Judy Burton Director of US Operations 2626 Valley View Lane, Suite 4 Dallas, Texas 75234-6274 NOV 3 0 2009 Re: K091248 Trade Name: MAXEMS, Models 1000 and 2000 Regulation Number: 21 CFR 890.5850 Regulation Name: Powered muscle stimulator Regulation Class: Class II Product Code: IPF Dated: November 10, 2009 Received: November 18, 2009 Dear Ms. Burton: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical {3}------------------------------------------------ # Page 2 - Ms. Judy Burton device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for vour device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportalProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Sincerely vours. Mark A. Milkeron Mark N. Melkerson Director Division of Surgical, Orthopedic, and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ # SECTION 4 - Indications for Use Statement #### Indications for Use 510(k) Number (if known): Device Name: MAXEMS 1000 / MAXEMS 2000 Indications For Use: - 1. Relax muscles - Prevention or retardation of disuse atrophy 2. - ന് Increasing local blood circulation - 4. Muscle re-education - Immediate post-surgical stimulation of calf muscle to prevent venous thrombosis 5. - Maintaining or increasing range of motion 6. Prescription Use (Part 21 CFR 801 Subpart D) AND/OR Over-The-Counter Use (21 CFR 801 Subpart C) (Please DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IFNEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) FOR M.MELKERSON Page 1 of 1 (Division Sign-Off) (Division Sign-Off) Division of Surgical, Orthopedic, and Restorative Devices 510(k) Number K091248 4-1 --- **Source:** [https://fda.innolitics.com/submissions/PM/subpart-f%E2%80%94physical-medicine-therapeutic-devices/IPF/K091248](https://fda.innolitics.com/submissions/PM/subpart-f%E2%80%94physical-medicine-therapeutic-devices/IPF/K091248) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com